December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theratechnologies Inc. - Common Shares (NQ:THTX)

3.390 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theratechnologies Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
Via Benzinga
Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says
 
Via Benzinga
Theratechnologies: Q3 Earnings Insights
Theratechnologies (NASDAQ:THTX) reported its Q3 earnings results on Thursday, October 13, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Theratechnologies Stock Jumps After Q2 Earnings, FY22 Guidance
 
Via Benzinga
Recap: Theratechnologies Q2 Earnings
  Theratechnologies (NASDAQ:THTX) reported its Q2 earnings results on Thursday, July 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Upgrades 
Via Benzinga
Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays
From Theratechnologies
Via GlobeNewswire
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
From Theratechnologies
Via GlobeNewswire
Earnings Scheduled For October 13, 2022
Companies Reporting Before The Bell • Valens Co (NASDAQ:VLNS) is estimated to report quarterly loss at $0.17 per share on revenue of $26.75 million. 
Via Benzinga
Earnings Preview: Theratechnologies
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Thursday, 2022-10-13. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium
From Theratechnologies
Via GlobeNewswire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
   Losers 
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! It's time for a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday! 
Via InvestorPlace
Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket
Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday. 
Via Benzinga
Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population
From Theratechnologies
Via GlobeNewswire
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,... 
From Theratechnologies
Via GlobeNewswire
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For July 14, 2022
Companies Reporting Before The Bell • Telefonaktiebolaget L M (NASDAQ:ERIC) is expected to report quarterly earnings at $0.16 per share on revenue of $6.45 billion. 
Via Benzinga
A Preview Of Theratechnologies's Earnings
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Thursday, 2022-07-14. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 49 companies set new 52-week lows. 
Via Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
Via Benzinga
Theratechnologies Earnings Preview
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion. 
Via Benzinga
Theratechnologies Q1 2022 Earnings Conference Call On April 13, 2022 At 08:30 AM ET
  Theratechnologies (NASDAQ:THTX) will host a conference call at 08:30 AM ET on April 13, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
Theratechnologies Q3 Earnings Lags Consensus As Trogarzo Sales Decline
Theratechnologies Inc (NASDAQ: THTX) reported Q3 sales of $17.85 million, +27% Y/Y propelled by higher Egrifta sales of $11.22 million, +64%. The revenue missed... 
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the... 
Via Benzinga
Earnings Scheduled For October 13, 2021
Companies Reporting Before The Bell • BlackRock (NYSE:BLK) is estimated to report quarterly earnings at $9.23 per share on revenue of $4.81 billion. • Delta Air... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.